These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3503768)

  • 1. Adenine nucleotides in erythrocytes from patients with peripheral vascular disease and the effects of oxpentifylline.
    Gleeson M; Maughan RJ
    Eur J Vasc Surg; 1987 Jun; 1(3):173-9. PubMed ID: 3503768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood and red cell ATP content in patients with peripheral vascular disease: the effect of cigarette smoking and oxpentifylline.
    Maughan RJ; Broom J; Smith G; Leiper JB; Ah-See AK; Engeset J; Evan-Wong A; Davidson RJ
    Angiology; 1984 Oct; 35(10):628-32. PubMed ID: 6497047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Angelkort B; Maurin N; Boateng K
    Curr Med Res Opin; 1979; 6(4):255-8. PubMed ID: 527350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
    Stuart J; Stone PC; Bilto YY; Keidan AJ
    J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Pentoxifylline on flap survival.
    Takayanagi S; Ogawa Y
    Plast Reconstr Surg; 1980 Jun; 65(6):763-7. PubMed ID: 7384277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.
    Leonhardt H; Grigoleit HG
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep; 299(2):197-200. PubMed ID: 909613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in red cell filterability after incubation with oxpentifylline.
    Dormandy J; Ernst E; Flute P
    Curr Med Res Opin; 1981; 7(8):520-2. PubMed ID: 7307544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pentoxifylline on filterability of normal red blood cells and their adhesiveness to cultured endothelial cells.
    Sowemimo-Coker SO; Turner P
    Eur J Clin Pharmacol; 1985; 29(1):55-9. PubMed ID: 2996906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenine nucleotides and adenylate anergy charge in erythrocytes in psoriasis].
    Kosenko EA; Kaminskiĭ IuG; Goncharenko MS
    Vopr Med Khim; 1987; 33(6):37-41. PubMed ID: 2833030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane.
    Schubotz R; Mühlfellner O
    Curr Med Res Opin; 1977; 4(9):609-17. PubMed ID: 590022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte deformability in a red cell ageing model.
    Leonhardt H; Grigoleit HG; Reinhardt I
    Ric Clin Lab; 1978; 8(1-2):65-71. PubMed ID: 705180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assay of erythrocyte ATP by chemoluminescence. Protective action induced by pentoxifylline on the depletion of energy from stored erythrocytes].
    Acciavatti A; Forconi S; Guerrini M; Pieragalli D; Del Bigo C; Galigani C; Di Perri T
    Ric Clin Lab; 1985; 15 Suppl 1():505-13. PubMed ID: 4035230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
    Cummings DM; Ballas SK
    Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythrocyte deformability in progressive muscular dystrophy and effect of pentoxifylline].
    Chen SS; Liu JS
    Taiwan Yi Xue Hui Za Zhi; 1986 Mar; 85(3):249-57. PubMed ID: 3462309
    [No Abstract]   [Full Text] [Related]  

  • 20. On the influence of pentoxifylline on the permeability of rat erythrocytes for methyl-O-glucose.
    Stefanovich V; Porsche E; Müller E
    Arzneimittelforschung; 1979; 29(5):757-60. PubMed ID: 582974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.